🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Carcinoma

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer NCT05534438Phase 28 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Stereotactic body radiotherapy Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. NCT07062965Phase 3433 sites📍 Anchorage📍 Chandler📍 Gilbert Pfizer · Tests: PF-07248144, Fulvestrant, Everolimus, Exemestane ETHAN - ET for Male BC NCT05501704Phase 29 sites📍 Washington D.C.📍 Jacksonville📍 Boston Jose Pablo Leone · Tests: Tamoxifen, Anastrozole, Degarelix, Abemaciclib PREgnancy and FERtility Registry NCT02895165n/a23 sites📍 Asti📍 Brindisi📍 Monserrato IRCCS Azienda Ospedaliera Universitaria San Martino - IST I… A Phase II Study of Biomarker-Guided De-escalation Using Anthracycline-Free Neoadjuvant Chemoimmunotherapy in Early-Stage Triple Negative Breast Cancer (TNBC) Patients With High Tumor-Infiltrating Lymphocytes (TILs) NCT07743190Phase 22 sites📍 Syracuse📍 Charleston Medical University of South Carolina · Tests: Carboplatin, Paclitaxcel, Pembrolizumab CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial NCT05360290NA1 site📍 Shanghai RenJi Hospital · Tests: GILUPI CellCollector® Stereotactic Ablative Radiotherapy for OligoMetastatic Breast Cancer NCT05377047Phase 319 sites📍 Cork📍 Cork📍 Dublin Vastra Gotaland Region · Tests: SABR A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse NCT06643585Phase 31 site📍 Ulm Prof. Wolfgang Janni · Tests: Trastuzumab-Deruxtecan, Physicians Choice (PhC). The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction NCT06995118NA20 sites📍 Fuzhou📍 Guangzhou📍 Anyang Du Zhenggui · Tests: HUAXI hole 1 PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC NCT06245889Phase 22 sites📍 Baltimore📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: Paclitaxel, Carboplatin, Pembrolizumab, Doxorubicin, Cyclophosphamide Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study NCT07059104n/a1 site📍 Gothenburg Vastra Gotaland Region · Tests: Breast augmentation, Breast reconstruction after mastectomy Novel MRI Techniques on Evaluation of Lymphedema NCT05804643n/a1 site📍 Taipei National Taiwan University Hospital · Tests: Diffusion magnetic resonance imaging Safety and Efficacy of IMPT or IMRT for Breast Cancer NCT06826885n/a1 site📍 Shanghai Ruijin Hospital · Tests: Postoperative radiotherapy, Preoperative Radiotherapy, Definitive Radiotherapy EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer NCT07704476NA2 sites📍 Pittsburgh📍 Pittsburgh Allegheny Singer Research Institute (also known as Alleghen… · Tests: Whey protein (60 grams), No protein Sensitivity of Organoids to Predict Treatment Outcome in Breast Cancer Metastases NCT06468124n/a2 sites📍 London📍 London King's College London A Study of Breast Cancer Risk Factors and Outcomes of People in Florida NCT06780176n/a3 sites📍 Los Angeles📍 Miami📍 New York Memorial Sloan Kettering Cancer Center · Tests: Biospecimen Collection, Surgical Tissue Collection, Survey Collection Compare Analgesia Between MTP Block And ESPB in MRM NCT06888258NA1 site📍 Cairo National Cancer Institute, Egypt · Tests: Ultrasound guided Erector Spinae Plane block, Ultrasound guided Mid-point to Pleura block A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib Viscum Album for TNBC on Adjuvant Pembrolizumab NCT06920810Phase 41 site📍 Goyang-si Ilsan Cha hospital · Tests: viscum album Pucotenlimab and Anlotinib in Combination With Chemotherapy NCT07896668Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: LP 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Endoscopic Nipple-Sparing Mastectomy Through a Single Axillary Incision in Breast Cancer NCT07507890NA1 site📍 Candiolo Fondazione del Piemonte per l'Oncologia · Tests: Endoscopic Nipple-Sparing Mastectomy (E-NSM) Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery NCT06297265NA1 site📍 Los Angeles University of Southern California · Tests: Lymphedema Management, Questionnaire Administration, Adjuvant breast radiation therapy Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer NCT06631092Phase 1, Phase 22 sites📍 Erlangen📍 Heidelberg NEC Bio B.V · Tests: Oral DNA Vaccine Facility-Based Multi-Modal Rehab vs. Home-Based Resistance Exercise for Quality of Life in Breast Cancer Survivors NCT07465393NA1 site📍 New Taipei City Valeria Chiu · Tests: Multimodal Resistance and Relaxation Training, Home-Based Resistance Exercise Training Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients NCT06722599n/a1 site📍 Beijing Shu Wang Prehabilitation With Resistance-exercise Training for Breast Cancer Neoadjuvant Therapy NCT06309290NA2 sites📍 Santiago📍 Temuco Universidad de La Frontera · Tests: Prehabilitation with resistance-exercise training, Usual care program
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy